Kelly Chin
Overview
Explore the profile of Kelly Chin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krasuski R, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper M, et al.
JACC Adv
. 2025 Feb;
4(3):101626.
PMID: 39999520
Background: Pulmonary arterial hypertension (PAH) is a common complication among patients with congenital heart disease (CHD). Despite advances in PAH treatment, evidence for the benefits of PAH therapies in CHD-PAH...
2.
Lawrie A, Chin K, Fong Y, Gargano C, Gitton X, He C, et al.
Pulm Circ
. 2024 Jun;
14(2):e12386.
PMID: 38868397
A blood test identifying patients at increased risk of pulmonary hypertension (PH) could streamline the investigative pathway. The prospective, multicenter CIPHER study aimed to develop a microRNA-based signature for detecting...
3.
Outcomes After Supraventricular Tachycardia Ablation in Patients With Group 1 Pulmonary Hypertension
Satish T, Chin K, Patel N
Cardiol Res
. 2023 Nov;
14(5):403-408.
PMID: 37936620
Background: Pulmonary hypertension (PH) is associated with right ventricular pressure overload and atrial remodeling, which may result in supraventricular tachycardias (SVTs). The outcomes of catheter SVT ablation in patients with...
4.
Puckrin R, Chua N, Chin K, Peters A, Duggan P, Shafey M, et al.
Br J Haematol
. 2023 Jan;
201(2):319-325.
PMID: 36625160
Although autologous stem cell transplantation (ASCT) can achieve durable responses in eligible patients with follicular lymphoma (FL), long-term follow-up is needed to determine if it has curative potential. This retrospective,...
5.
Hinkamp C, Bartolome S, Mims E, Chin K, Shah T
Biomed Hub
. 2022 Dec;
7(3):115-124.
PMID: 36465803
Introduction: Parenteral prostanoids are the most potent therapies for pulmonary arterial hypertension (PAH) but are associated with complications and lifestyle limitations. Carefully selected stable patients may be considered for a...
6.
Frantz R, Benza R, Channick R, Chin K, Howard L, McLaughlin V, et al.
Pulm Circ
. 2021 Nov;
11(4):20458940211057071.
PMID: 34790348
Aberrant kinase signaling that involves platelet-derived growth factor receptor (PDGFR) α/β, colony stimulating factor 1 receptor (CSF1R), and stem cell factor receptor (c-KIT) pathways may be responsible for vascular remodeling...
7.
Liberman T, Roofeh R, Chin J, Chin K, Razack B, Aquilino J, et al.
J Emerg Nurs
. 2021 Oct;
48(1):22-31.
PMID: 34649729
Background: The coronavirus disease 2019 pandemic caused an unprecedented surge of patients presenting to emergency departments and forced hospitals to adapt to provide care to patients safely and effectively. The...
8.
Kerr K, Elliott C, Chin K, Benza R, Channick R, Davis R, et al.
Chest
. 2021 Jun;
160(5):1822-1831.
PMID: 34090871
Background: The United States Chronic Thromboembolic Pulmonary Hypertension Registry (US-CTEPH-R) was designed to characterize the demographic characteristics, evaluation, clinical course, and outcomes of surgical and nonsurgical therapies for patients with...
9.
Griffin D, Jensen A, Khan M, Chin J, Chin K, Saad J, et al.
J Glob Antimicrob Resist
. 2020 Nov;
24:90-92.
PMID: 33242672
Here we present a case series of three patients with COVID-19 (coronavirus disease 2019) who had a cytokine panel that revealed elevation of interleukin-6 (IL-6) but normal levels of interleukin-10...
10.
Griffin D, Jensen A, Khan M, Chin J, Chin K, Parnell R, et al.
Br J Haematol
. 2020 May;
190(1):e11-e13.
PMID: 32374029
No abstract available.